S
Svas Biosana SpA
MIL:SVS
Svas Biosana SpA
MIL:SVS
Price:
8.18
EUR
-0.73%
Market Cap:
€43.6m
Relative Value
The Relative Value of one SVS stock under the Base Case scenario is 17.56 EUR. Compared to the current market price of 8.18 EUR, Svas Biosana SpA is Undervalued by 53%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SVS
Relative Value
Base Case
17.56
EUR
Undervaluation 53%
S
Multiples Across Competitors
SVS Competitors Multiples
Svas Biosana SpA Competitors
Svas Biosana SpA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
S
|
Svas Biosana SpA
MIL:SVS
|
43.3m EUR | 0.3 | 6.4 | 3.2 | 4.8 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.1 | 37.1 | 26.8 | 32.2 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56.3B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF | 3.8 | 40.3 | 15.4 | 30 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
102.2B DKK | 3.7 | 25.8 | 13.5 | 16.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.1B USD | 3 | 29.5 | 12.7 | 17.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP | 2.6 | 36.8 | 14.6 | 24.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.1B USD | 1.2 | -16.8 | 17.6 | 56.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.1B CNY | 9.3 | 25.5 | 23.1 | 23.1 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
857.3B JPY | 6.6 | 48.5 | 22.9 | 31.1 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 3.5 | 23 | 14.6 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
